stockrowIQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.
- Revenue
- +8.00%
- EPS
- +10.2%
- Free cash flow
- −21.3%
- Total debt
- +7.42%
Quarter to September 2026, against a year earlier
Follow IQV
Alert me
IQVIA Holdings Inc. (IQV) Gross margin
IQVIA Holdings Inc.'s gross margin over the twelve months to 30 September 2026 was 33.1%, down 0.2 percentage points from fiscal 2025 (33.3%). Over the past ten years it has ranged from 28.3% (fiscal 2015) to 35.2% (fiscal 2018); the current reading is higher than 27% of that period. That is below the Diagnostics & Research industry median of 48.3% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 33.3% | (1.60) |
| FY2024 | 34.9% | (0.07) |
| FY2023 | 35.0% | 0.07 |
| FY2022 | 34.9% | 1.44 |
| FY2021 | 33.5% | (0.52) |
| FY2020 | 34.0% | (0.19) |
| FY2019 | 34.2% | (1.05) |
| FY2018 | 35.2% | 0.16 |
| FY2017 | 35.1% | 4.72 |
| FY2016 | 30.3% | 2.07 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 33.8% | 0.98 |
| Jun 2026 | 32.9% | 0.21 |
| Mar 2026 | 32.6% | (0.27) |
| Dec 2025 | 32.9% | (0.58) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ILMN Illumina, Inc. compare | 67.9% |
| IDXX IDEXX Laboratories, Inc. compare | 62.7% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| A Agilent Technologies, Inc. compare | 53.8% |
| WAT Waters Corporation compare | 49.5% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| IQV IQVIA Holdings Inc. | 33.1% |
| LH Labcorp Holdings Inc. compare | 29.0% |
| NTRA Natera, Inc. compare | 0.00% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on IQV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement